Current Clinical Trials
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Srivatana M.D., Ukorn
Sub-Investigator(s):
Sponsor: Amgen
Indentifier #: n/a
Title: Validation of the Ulcerative Colitis Patient-Reported Outcomes (UC-PRO) Instrument in Patients with Ulcerative
Colitis (A-12594)
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lynch MD, Cynthia A.
Sub-Investigator(s):
Sponsor: SWOG
Indentifier #: NCT01272037
Title: S1007, A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less
Department: Cardiology
Diagnosis: Cardiac - Peripheral vascular disease
Principal Investigator: Larson MD, RVT, FACS, Robert
Sub-Investigator(s):
Sponsor: Astra Zeneca
Indentifier #: NCT01732822
Title: A randomized, double-blind, parallel group, multicenter phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischemic stroke in patients with established Peripheral Artery Disease
Department: Oncology
Diagnosis: Gastrointestinal - Pancreas
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT01525550
Title: A6181202, A Single Arm Open-Label International Multi Center Study Of The Efficacy And Safety Of Sunitinib Malate (SU011248, Sutent®) In Patients With Progressive Advanced Metastatic Well Differentiated Unresectable Pancreatic Neuroendocrine Tumors
Department: Oncology
Diagnosis: Gastrointestinal - Pancreas
Principal Investigator: Lash MD, Bradley
Sub-Investigator(s):
Sponsor: SWOG
Indentifier #: NCT01658943
Title: S1115, Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) VS mFOLFOX in Patients with Metastatic Pancreatic Cancer After Prior Chemotherapy